The reagent on-board stability of the specific enzyme, GHB dehydrogenase, is significantly improved now. The enzyme is stable for 8 weeks even at storage temperature up to 15°C which is used in several clinical chemistry analyzers. In the last few years the amount of seizures of GHB (gamma-hydroxybutyric acid) continuously increased. Besides the well described
- info@buhlmannlabs.ch
- +41 61 487 12 12
Tag Archives: clinical chemistry
Today, reliable quantitation of vitamin status of a patient is done mainly with classical HPLC methods asking for time consuming and cumbersome sample precipitation and derivatization with highly toxic agents. The new enzymatic vitamin B6 assay from BÜHLMANN offers highly comparable results with the advantage of batch-wise sample measurements within 45 minutes. The assay employs
The new BÜHLMANN assay ACE high sensitive allows the reproducible measurement of Angiotensin Converting Enzyme activity in cerebrospinal fluids (CSF). The assay is the first commercially available CE marked test on the market and can be applied either on microtiter plates or on flexible clinical chemistry analyzers with a limit of detection of 1 U/L.
Determination of GHB (liquid Ecstasy) in human samples was a challenge until today. Expensive and laborious chromatographic methods did not allow the prompt determination of suspicious samples. The BÜHLMANN GHB enzymatic assay will give the toxicology laboratories a quick, easy and cost efficient screening tool to investigate even samples with lower suspicion. The GHB enzymatic assay
Social Links